Bronchoscopic biopsy of the central-chest lymph nodes is an important step for lung-cancer staging. Before bronchoscopy, the physician first visually assesses a patient's three-dimensional (3D) computed tomography (CT) chest scan to identify suspect lymph-node sites. Next, during bronchoscopy, the physician guides the bronchoscope to each desired lymph-node site. Unfortunately, the physician has no link between the 3D CT image data and the live video stream provided during bronchoscopy. Thus, the physician must essentially perform biopsy blindly, and the skill levels between different physicians differ greatly. We describe an approach that enables synergistic fusion between the 3D CT data and the bronchoscopic video. Both the integrated planning and guidance system and the internal CT-video registration and fusion methods are described. Phantom, animal, and human studies illustrate the efficacy of the methods.
INTRODUCTION
Interventional biopsy of the central-chest lymph nodes is an important step for staging lung cancer [1] . Trans-bronchial needle aspiration (TBNA) is often used to sample lymph nodes for pathology [2] [3] [4] [5] . To perform TBNA, the physician first visually assesses a patient's computed tomography (CT) scan to identify suspect lymph-node sites. Later, during subsequent live bronchoscopy, the physician guides the bronchoscope to each desired lymph-node site.
The physician must use prior experience and the available 3D CT chest data to do this guidance.
This requires the physician to do 3D mental reconstruction of the anatomy to ascertain each biopsy site. CT, however, only provides transverse-plane (x-y) sections of the chest anatomy, and it is well-known that physicians have difficulty properly identifying airways in CT data by as early as the second generation [6, 7] . Thus, effective bronchoscopy path planning can be difficult. Further, the target lymph nodes are behind airway walls and hidden from the bronchoscope's field of view. It has been shown that the act of positioning the biopsy needle is extremely stressful to the bronchoscopist and that the skill level of bronchoscopists varies significantly [8] . Overall, this results in low biopsy yields [3] .
The development of virtual bronchoscopy (VB) has led to interest in introducing CT-based computer-graphics techniques into the procedure of lung-cancer staging [9] [10] [11] [12] [13] [14] . In VB, the 3D CT image serves as a high-resolution digital-image replica of the chest. Interior (endoluminal) renderings of the airways can be generated along paths following the airway central axes and lead to an off-line simulation of live videobronchoscopy. VB is a subspecialty of the general field referred to as virtual endoscopy [15, 16] . In virtual endoscopy, interior views of organs are computer-generated from radiologic images. This is similar to the situation where interior video views of organs are presented during real endoscopy.
VB has inspired proposals where computer-based image guidance assists the physician in performing TBNA. These proposals, summarized below, show promise, but can be improved upon: lymph-node biopsy, but these efforts involved no live guidance [3, 4] ; (2) Bricault et al. did rudimentary registration of 3D CT chest data to videobronchoscopy, but their results were limited [17] ; (3) other researchers have proposed a fundamentally different approach whereby an extra electromagnetic sensor is attached to the bronchoscope tip -this approach also requires considerable extra hardware [5, 18, 19] ; (4) Mori et al. registered videobronchoscopy images directly to rendered 3D CT images and also proposed including an electromagnetic sensor, but their efforts do not work interactively [20, 21] .
Our efforts go beyond mere endoluminal renderings. Central to our work is the registration and fusion of radiologic CT image data and live endoscopic video. We propose a method for performing this registration and fusion and describe a system that applies the method to the planning and guidance of live bronchoscopy. Before the procedure, a 3D multi-detector CT (MDCT) chest scan is analyzed with the system. The physician constructs a multimedia case study that contains a list of predefined biopsy sites and a 3D airway path to each biopsy site. Next, the system is brought into the bronchoscopy laboratory and interfaced directly to the bronchoscope. The system then enables CT-video registration and fusion and provides live interactive bronchoscopic guidance to each biopsy site.
Before continuing, we give a general history of the major technologies involved in modern lungcancer assessment: CT scanners, videobronchoscopes, and 3D computer-based visualization tools.
Note that CT scanners have been in use for roughly 30 years and have many well accepted diagnostic uses. Also, new MDCT scanners readily give very large high-resolution 3D volumetric images of the chest [12, 14, 22] (Figure 1a) . Similarly, bronchoscopes have been in regular clinical use for over 35 years. They also have many accepted diagnostic uses and provide high-resolution full-color realtime video of the interior wall structure of the human airways ( Figure 1b) [2, 5] . Yet, CT scanners and videobronchoscopes have major limitations for assessing and staging lung cancer [22, 23] .
FIGURE 1 HERE.
Modern MDCT scanners provide an enormous amount of high-resolution image data of the human chest. Unfortunately, physicians still primarily rely on either view panels to view a CTscan film study or on computer workstations to do simple scrolling through CT slice data. Thus, the information contained in MDCT scans is woefully underutilized -this is a well-recognized problem in current radiology research [12, 24] . Bronchoscopes have a related limitation in that they do not enable the physician to see beyond (extraluminally) the airway walls, nor do they enable the physician to see beyond the current position of the device; i.e., there is no look ahead [23] .
Many 3D visualization techniques have been devised for more exhaustively viewing the information contained in 3D MDCT chest images. Examples of techniques are surface and volume rendering, multi-planar reformatted (MPR) slice viewing, projection imaging, thin-slab viewing, and endoluminal (virtual endoscopic) rendering [10, 12, 14, [23] [24] [25] [26] . But, in reality, the visualization actually used in clinical practice is limited to previewing transverse-plane 2D slice images, occasional coronal and sagittal MPR sections, gray-scale windowing and thresholding to highlight structures of interest, and simple annotation and report generation. In addition, tools such as fluoroscopy and CT fluoroscopy are often available to the bronchoscopist, but they only provide either projection views or single 2D slice views and require extra radiation during a procedure [1, 27] . Thus, the clinical use of visualization tools for lung-cancer assessment still lags behind the developments made in the research laboratory.
Our efforts have attempted to close this gap. Our methods enable direct 3D CT-based procedure planning and provides direct 3D guidance during bronchoscopy. 3D CT-based information on biopsy sites is provided interactively as the physician moves the bronchoscope. Moreover, graphical information through a live fusion of the 3D CT data and bronchoscopic video is provided during a procedure. This information is coupled with a series of computer-graphics tools to give the physician a greatly augmented view of the patient's anatomy during a procedure. Section 2 of this paper overviews the basic system, while Section 3 describes the CT-video registration and fusion methods. Next, Section 4 provides a series of phantom, animal, and human results. Finally, Section 5 offers some concluding comments.
SYSTEM OVERVIEW
We first give an overview of the complete lung-cancer assessment system. The sections below overview the basic system hardware (Section 2.1), computer-based graphical user interface (Section 2.2), and basic system operation (Section 2.3). Figure 2 gives a block diagram of the system's hardware. A standard Windows XP PC, equipped with a mid-range video card, serves as the main CPU unit. A Matrox Meteor-II frame grabber, driven by the MIL-Lite software library and plugged into one of the PC's PCI slots, acts as the interface to the live real-time video stream (30 frames per sec) from a bronchoscope's video output.
System Hardware
The system's software architecture was initially conceived using the Unified Modeling Language (UML) and Rational Rose [28, 29] . All software is written in C++ and maintained in Visual 
System Graphical User Interface
The system is used in two stages, per the basic lung-cancer assessment paradigm: Stage-1 MDCT Assessment and Planning followed by Stage-2 Image-Guided Bronchoscopy. The software is run through an integrated graphical user interface (GUI). Through the GUI, the user invokes interactive protocols for building a case study during Stage-1 MDCT Assessment and for performing live imagebased guidance during Stage-2 Bronchoscopy. As described more below, the case study stores the following information for an incoming case: (1) segmented airway tree; (2) airway-tree endoluminal and extraluminal surface representations; (3) airway central axes (or centerlines); and (4) regions of interest (ROIs) signifying diagnostically important biopsy sites, such as lymph nodes or suspect cancer nodules.
The system has a wide range of interactive visualization tools. 10. Tube Viewer -Gray-scale cross-sections, interior renderings, and 3D topographic maps can be computed along mathematically unraveled (straightened) sections (tubes) of MDCT data along a 3D axis [23, 33, 40] . This gives a means for viewing data along a complete, and in general, tortuous airway path.
11. Plot Tool -A plot of geometric measurements along an airway (e.g., cross-sectional area, maximum airway diameter) can be displayed [23, [37] [38] [39] [40] . The user can point to a selected site along this plot to see graphical manifestations of the MDCT data at this site. 
Top-Level System Operation
Below, we summarize system usage during the two stages of operation. Stage 1 is only briefly highlighted in this paper, with other references giving more detail. For airway tree segmentation, we have used methods based on 3D region growing and mathematical morphology [41] . For central-axes extraction, we have drawn upon techniques based on 3D thinning, B-spline analysis, and differential geometry [37, 39, 42] . For ROI definition, either direct manual slice tracing or more robust semi-automatic live-wire analysis have been used to identify region borders [32, 43, 44] . Surface data is generated using the well-known Marching Cubes algorithm built into the VTK package [30] . All Stage-1 methods have undergone considerable validation using real human data and are discussed in detail in previous publications.
After the analysis above is complete, the user previews the case information using various available visualization tools. Figure 4 gives an example during this step for an animal study. At the end of Stage-1 analysis, a case study exists that captures many data elements for follow-on report generation and a biopsy path plan to reach each ROI during subsequent Stage-2 Bronchoscopy. FIGURE 4 HERE.
Stage 2: Image-Guided Bronchoscopy
Given the case study, a technician connects the bronchoscope's video stream to the computer system, as illustrated in Figure 2 . The system's GUI is then set up in preparation for live bronchoscopic guidance. Figure 5 gives a system view during Stage-2 bronchoscopy for same pig study as Figure   4 , while Figure 14 , discussed later, gives a view during a patient study.
Before proceeding, we must discuss the linkage between the two available data sources. As pointed out by Figure CT (x, y) denote an initial MDCT-based endoluminal rendering at initial viewpoint χ i . During registration, the following optimization is run to search for the optimal viewpoint χ o :
I χo CT (x, y) is the endoluminal rendering best matching the fixed video frame I F V (x, y). In (1) , N χ i is the search neighborhood about χ i and S N M I represents the normalized mutual information (NMI) between I χ CT (x, y) and I F V (x, y) [45] . Section 3 gives more detail on the optimization (1). With this introduction, we now describe the basic Stage-2 operation of the system. To guide the physician to each lymph-node ROI site, the following steps are taken:
1. Select the case study's precomputed path that was found during Stage 1 to lead to the lymph-node site. CT (x, y), where χ i is the initial viewpoint as represented in the selected 3D site's data structure.
Generally, the site is selected by picking a point on a 2D coronal projection of the 3D MDCT data set and associated computed central axes. The point is picked on the highlighted path activated in step 1. As a rule for bronchoscopy, the first selected site is generally within the trachea near the main carina. 
CT-VIDEO REGISTRATION AND FUSION
Details on the internal registration and fusion processes are given below. In particular, Section 3.1 describes the physical models underlying I CT and I V and the basic registration operation, while Section 3.2 details the optimization methods. Finally, Section 3.3 describes how fusion is accomplished between the CT and video data. For this paper, we follow the notational conventions of [46] .
Source Modeling and the Registration Method
As mentioned earlier, the endoscopic video I V (x, y) and endoluminal renderings I CT (x, y) act as cameras observing the same 3D space. To facilitate one-to-one pixel-based (x, y) registration be-tween these two cameras, we first measure off-line (before a procedure) the focal length and fieldof-view dimensions of the bronchoscope. These quantities are easily measured, per [46, 47] . The measured quantities are then used to compute endoluminal renderings I CT (x, y) for the virtualworld camera.
For our work, we use the luminance (gray-scale) component of the bronchoscope's video.
Okatani and Deguchi have shown that the illuminated endoluminal airway walls can be modeled as a Lambertian surface and that the brightness of an airway surface point p can be specified by [48] 
where L is the intensity of the bronchoscope's light source, θ s is the angle between the light source and p's surface normal, R is the distance from the light source to p, and σ is a proportionality factor that takes into account airway-surface albedo and the bronchoscope's device characteristics [46] .
The final 2D point I V (x, y) then results from a standard 3D-to-2D transformation of I(p).
For computing the endoluminal renderings, the value I χ CT (x, y) of a particular screen point (x, y), which corresponds to an observed surface point p, abides by a model similar to the endoscope Lambertian shading model of (2):
Eq. (3) differs from (2) in three important ways:
1. An ambient light factor L a is included to approximate the indirect lighting.
2. The denominator arising from the range attenuation term is forced to stay > 0, which is again required for real computer-based rendering. R is derived from a known range map (derived from the previously computed airway-tree surface data) and measured in mm for (3).
3. The bronchoscope's light source is in fact close to the surfaces it is illuminating. Hence, the light source in fact changes in illumination intensity as one moves off the axis of the light source (same as the camera axis). The attenuation factor (cos φ p ) 1/2 , where φ p is the angle between the camera axis and the vector pointing toward point p, represents this illumination change.
Eq. (3) is easily implemented by the OpenGL command gllightf() and contrast scaled for an eight-bit gray-scale display [31] . Note that (2) is a model for a video frame I V (x, y) (we do not have control over this), while (3) is our controllable implementation of the CT-based camera producing frames I CT (x, y). Extensive results for controlled and real tests, given in [46] , have validated the efficacy of these models.
Equation (1) is the central optimization performed during CT-video registration. The discussion below gives more detail on (1) . S N M I is defined as [45, 46] :
where h(V ) and h(CT ) are entropy-like quantities for I V and I CT , and h(V, CT ) is a joint entropy between I V and I CT ; h(V ) is given by
where p V (k) is the probability density function (pdf) for the pixel gray-level values contained in I V ,
is the joint gray-scale histogram between I V and I CT , and the w k (and w l ) are weights.
The pdf p V (k) is estimated as the normalized histogram of I V , per:
while the quantity p V,CT (k, l) is the 2D joint intensity pdf between the two images I CT and I V defined as
In ( have definitions similar to (4). Finally, the weights are set to favor the more informative darker pixels:
As observed by Bricault, the darker areas in I V and I CT give "more useful information," as they correspond to significant features such as upcoming airway bifurcations and other airway-wall deviations, whereas the bright "bland" areas offer little useful information [17] . Reference [46] gives further discussion on the quantities above. Figure 6 gives an example of the quantities used in the optimization. Despite the differences in the image pdf's, the similarities between the two data sources are apparent. This similarity for most pixel locations (x, y) in the two frames; the quantity b > 0 represents the ambient intensity bias in the video frame, which is generally brighter on average than the endoluminal rendering.
FIGURE 6 HERE.
Optimization
We applied three optimization techniques for solving the registration problem: (a) brute-force steepest ascent [49, 50] ; (b) simplex [51, 52] ; and (c) simulated annealing [53] . In our early efforts, we found that the steepest-ascent approach often converges to a proper optimum, but it is also vulnerable to unwanted local optima [49, 50] . Thus, we have abandoned it as a viable alternative. Thus, the best value found during all operations of a step is saved and used as the starting value for iteration with the next temperature step.
FIGURE 8 HERE.
Both the simplex and simulated-annealing algorithms always gave satisfactory maxima, provided that the viewpoint χ i of the initial input CT rendering I χ i CT (x, y) started sufficiently close to the optimal viewpoint χ o . Reference [46, 50] give extensive tests on the sensitivity of the op-timization methods to starting point χ i . It was found that individual spatial position values, X, Y , or Z, could vary ≥ ±6 mm and viewpoint angles, α, β, or γ, could vary ≥ ±20 o from χ o and result in proper convergence. Given that a typical airway has a diameter on the order of 10mm, these values imply great flexibility in starting point. Our tests indicate that the steepest ascent method required 8.91 sec per optimization, simplex 23.16 sec, and simulated annealing 24.04 sec on a dual-processor 933MHz PC. We in general used the simplex method in our tests.
CT-Video Fusion
Once the optimization (1) The second important processing step toward computing a fused view involves how the view is actually computed. With the FOVs matched between the virtual CT world and the real bronchoscopic video world, it is a straightforward matter to map the ROI surface into the 2D space observed by the video source; this involves a simple projection operation. So as not to obscure the underlying video, the ROI is rendered transparently onto the video frame.
We emphasize that for our application the real target is never visible in the video, as the lymph nodes are situated outside the airway interior. By fusing the CT information with the live video information, the system is able to provide live guidance information on extraluminal biopsy sites that would not otherwise be visible.
In addition to view fusion, several quantitative distances are computed on the fly during the procedure and presented by the Video Match tool. Referring to the Video Match tool in Figure 3 , "Min Airway to ROI Surface" represents the minimum distance of any of the visible ROI points in the center panel to the airway surface. "Dist to ROI Center" represents the distance from the FOV center to the ROI's centroid. "Airway Surface" gives the distance of the airway location pointed to by the cursor (arrow in center panel) to the airway-wall surface, while "Airway to ROI Surface" gives the distance of the airway-wall location pointed to by the cursor to the ROI surface (these two distances appear in the footer of the Video Match tool). Therefore, the sum of these two distances gives the total distance of the cursor's airway location to the ROI surface.
RESULTS
This section gives results for phantom, animal, and human studies.
We first tested the biopsy accuracy of our system for a controlled phantom experiment. The phantom used was a translucent rubber airway-tree replica, with six 1.4mm-diameter platinum beads glued to its exterior surface. The beads served as ROI "biopsy sites." An MDCT scan was made for the phantom, and Stage-1 MDCT Assessment and Planning operations were performed.
Two physicians used our system during bronchoscopy to "biopsy" each bead. During guided bronchoscopy, the computer display included the 3D Surface tool, Coronal Projection, Transverse Slicer, Coronal Slab, and Video Match Tool. The procedure of Section 2.3.2 was used to guide the physician to each bead. The physician stuck a biopsy needle into the phantom's rubber wall as the best biopsy point. Figure 9 shows a set of views from the Video Match tool when a physician is contemplating a biopsy. A measurement was then taken with a caliper as the distance between the metal bead and the line perpendicular to the needle direction. Figure 10 shows that the average biopsy error for the two physicians was 1.97mm. Typical chest diagnostic sites have a diameter ≥10mm; hence, these results are very encouraging. A follow-up test with the same phantom involving six physicians gave an average error of 1.57mm [46] . This compares very favorably to another trial involving the same six physicians performing the biopsies using the standard unguided CT-film approach (average error = 5.53mm). In fact, this test revealed that the six physicians not only all improved in performance, but they also became nearly indistinguishable in performance. This implies that the difference in physician skill level does not affect biopsy performance.
FIGURES 9-10 HERE.
We next performed five pig studies. These studies enabled us to test the system's feasibility, safety, and effectiveness during controlled in vivo circumstances, without the pressure of worrying about procedural errors such as puncturing major vessels. They also motivated tests of system reliability and new system enhancements.
Each pig was administered general anesthesia, transferred supine onto the CT scanner table, and placed on a PC pressure and ECC monitor. An Imatron EBCT scanner was used for the first three studies, while a Marconi Mx8000 MDCT scanner was used for the final two studies. A lung volume controller stabilized the chest volume at functional residual capacity during a CT scan [55] .
In all studies, we first performed a 3D CT scan of the animal, applied Stage-1 MDCT Analysis (e.g., Figure 4) , and then defined several "virtual" ROIs within the CT data. These steps took approximately five to ten minutes. Then, during Stage-2 Bronchoscopy, we used the system to guide the physician to each virtual ROI (e.g, Figure 5 ). Upon reaching a biopsy site, the physician then either deposited a dye marker or a metallic dart at the site. Figure 11 illustrates a system view after a dart was deposited at one virtual site. The animal then underwent a second CT scan.
Next, the initial CT scan (with virtual ROIs) and the second CT scan (with dye markers or darts)
were compared. Figure 12 shows comparison 3D CT views that indicate the ROI target region and placed platinum dart. In this experiment the ROIs were below the airway wall, but the dart could only penetrate the surface, making the final dart position slightly above the initial ROI. Figure 12 show that the dart for the ROI seemed to be placed well near the target, indicating proper guidance to this region.
FIGURES 11-12
The animal studies, done over a two-year period, helped to introduce additions and improvements to the system, such as the distance calculations now present in the Video Match tool [56] .
Also, software bugs, such as a memory leak that caused the system to freeze after 5-10 continuous minutes of live operation, were fixed. For the final animal study performed with the MDCT scanner, we placed six ROIs within the two lungs, spaced at locations near generation-2 and generation-5 airways. For these studies, we achieved the following results: average distance from the ROI center:
4.95mm; average distance from the ROI: 2.37mm.
The errors achieved by the animal studies are again small. As another point, the animal studies also gave us the opportunity to test the overall safety of the system. In particular, we wanted to see if the system provided misleading information such as guidance to major arteries that should not be punctured. We observed no such events during these studies. We did observe, however, that for one peripheral biopsy site, the 6mm-diameter Olympus bronchoscope used for the studies could not be physically manipulated within the airway near the site. Hence, the biopsy could not be done. But, this is a limitation of the device, not our system. Current ultrathin bronchoscopes (diameters on the order of 2.8mm) offer promise for navigating through small airways [57] [58] [59] .
After establishing general reliability and safety through the animal studies, we next performed a pilot study of the system under real clinical circumstances. Figure 13 presents information on eleven human lung-cancer patients enrolled in the study. All patients had known mediastinal adenopathy and were enrolled under informed consent. For each patient, a 3D MDCT chest scan was done using a Philips 4-detector Mx8000 MDCT scanner. Patients held their breath for 20 sec. during a scan. We then went through Stage-1 MDCT Assessment and Planning operations to arrive at a computer-based case study and all preplanned ROI biopsy sites.
In the bronchoscopy laboratory, the system was then interfaced to the bronchoscope, per Figure   2 . For each planned site, the physician received continuous image guidance data and performed the appropriate biopsy. For immediate confirmation, cytology was done after each biopsy. Three different medical-school staff physicians, typically assisted by fellows-in-training, performed the procedures.
Case RJ represented the first "dry run" system test. The goal of case RJ was to gain confidence with the experimental apparatus in a real clinical scenario. The system was applied successfully in all tests. For case PK, the physician erroneously defined a blood vessel segment as the ROI. This was not a malfunction of the system, as the available system viewing tools clearly were able to show that this site was a blood vessel. In fact, the system actually guided the physician "successfully" to this ROI during the procedure. As with any new device, this test did show that caution and proper training are necessary to use the system properly. Figure 14 presents a captured computer screen for case HW, where the live bronchoscopy needle appears in the view. As a result of this procedure, the nodal region samples showed cancer consistent with the patient's known previous renal cell information. FIGURES 13-14 HERE.
DISCUSSION
Several issues warrant discussion regarding the proposed image-guided bronchoscopy system. First, during a bronchoscopy, the physician must cooperate in that the bronchoscope cannot be moved too quickly. This requirement adds no undue burden, as the physician generally tends to hover over sites of interest within the airways. The quickest movements occur when the physician pulls the bronchoscope away from a site after finishing a biopsy. Bear in mind that the distances that the bronchoscope is moved is measured in mm and cm -small movements are the rule. A second issue involves the differing chest volumes during MDCT scanning (patient holds breath and the lungs are near full inflation) and during bronchoscopy (patient is doing low-level tidal breathing and the lungs stay largely deflated). We have found through laboratory and animal studies that this phenomenon has no impact on the guidance [46] . This is apparently true, because the airways are largely rigid cartilaginous structures and the working environment during CT-video registration is very small (on the order of a few cm 3 ). A final issue involves events occurring during bronchoscopy, such as patient coughs, water bubbles, airway-wall obscurations (the bronchoscope tip goes against an airway wall obscuring the view). We have considered some preliminary efforts to detect such events [60] .
Other emerging tools could conceivably improve the overall efficacy of our system. Endobronchial ultrasound (EBUS) has the ability to detect a desired ROI locally during bronchoscopy [61] . EBUS could synergistically complement our system's guidance, but further miniaturization of the EBUS device would be necessary for them to be feasible at peripheral sites. Positron emission tomography (PET) and the recent innovation of combined PET-CT scanners adds yet another tool for procedure planning [61] [62] [63] . While researchers assert that PET can specifically identify positive cancer sites, its inherent low resolution limits its diagnostic capability for small lesions. In addition, direct in vivo diagnostic intervention with bronchoscopy would still be required to confirm a diagnosis.
The phantom, animal, and human studies done to date have helped confirm the safety and minimal risk in using the system. There is essentially no risk, as the physician can merely ignore the computer and follow only the bronchoscopic video as ever. Note that the current system already fits readily into the clinical work flow, with technicians performing nearly all tasks. During Stage-1 MDCT analysis, the physician's only task is to point out ROIs, while during Stage-2 bronchoscopy, the physician does nothing extra except look at the system's computer monitor.
Other researchers have demonstrated recently that VB-based guidance during bronchoscopy can provide the necessary means for successful peripheral nodule biopsy [64, 65] . But more definitive 3D MDCT-based path planning would offer a more exhaustive and straightforward means for preplanning appropriate endobronchial routes for maneuvering the bronchoscope through the complex airway tree and would specify the final biopsy site (often invisible in current practice) definitively [66] . Finally, recent developments in real-time continuous CT-video registration during bronchoscopy could potentially further improve image-based guidance [67, 68] .
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This work was partially supported by grants #CA074325 and #CA091534 from the National Cancer illustrates the case study. Lower left view shows a 3D Surface Tool view of the segmented airway tree, extracted axes (red lines), five ROIs of various colors (small blobs external to the rendered tree), and a coronal slice passing through the selected 3D site; the selected site appears as a small green needle intersecting by yellow orthogonal reference axes. Top left view is a coronal depth-weighted maximum thin-slab; the red dot indicates the current 3D site. Lower center view is an endoluminal rendering of the selected 3D site, where the red lines are the extracted airway axes again, the green blob is the green ROI also seen in the 3D Surface tool; note that transparency is used for this rendering, so that the green ROI becomes visible. The lower right dialog is a coronal maximum-intensity projection (MIP) of the 3D MDCT data set, and the red lines again indicate the extracted central axes. Calculate vertices of initial simplex (N=6):
Note the best and worst vertices and associated NMI measures: χ min , χ max , S min , S max Get reflection of χ min across face of simplex: Figure 10 : Phantom biopsy results. Two physicians used the proposed system to "biopsy" a rubber human airway-tree phantom enhanced with six platinum beads serving as ROIs. A 453×155×160 MDCT scan (Marconi Mx8000 4-detector scanner; ∆x = ∆y = 0.35mm and ∆z = 1.5mm) was made. "Distance" gives the average biopsy error over measurements made for five beads. "Std Dev" is the standard deviation of the measurements. "Average" represents the average biopsy results over the three trials. 
SUMMARY
Interventional biopsy of the central-chest lymph nodes is an important step for staging lung cancer. Trans-bronchial needle aspiration (TBNA) is often used to sample lymph nodes for pathology. To perform TBNA, the physician first visually assesses a patient's computed tomography (CT) scan to identify suspect lymph-node sites. Later, during subsequent live bronchoscopy, the physician guides the bronchoscope to each desired lymph-node site. Unfortunately, the physician has no link between the 3D CT image data and the live video stream provided during bronchoscopy.
In addition, these data sources differ greatly in what they physically give. This makes it difficult for the physician to translate a CT-based procedure plan to the video domain of the bronchoscope.
Thus, the physician must essentially perform biopsy blindly, and the skill levels between different physicians differ greatly. We describe an approach that enables synergistic fusion between the 3D
CT data and the bronchoscopic video. Both the integrated planning and guidance system and the internal CT-video registration and fusion methods are described. Given models for the CT and video sources, we use an optimization method based on normalized mutual information to register the 3D CT data to the live bronchoscopic video source. This then enables computer-graphics-based fusion of CT information with the video. During bronchoscopy, 3D CT-based information on biopsy sites is provided interactively as the physician moves the bronchoscope. Moreover, graphical information through a live fusion of the 3D CT data and bronchoscopic video is provided during the procedure. This information is coupled with a series of computer-graphics tools to give the physician a greatly augmented reality of the patient's interior anatomy during a procedure. A series of controlled phantom and animal studies and studies with human lung-cancer patients illustrate the efficacy of the system.
